Dr Davide Danovi

Davide’s group at the Centre for Stem Cells and Regenerative Medicine launched within the framework of the Human Induced Pluripotent Stem Cells Initiative (HipSci) project, funded by Wellcome and MRC. Within this framework, his team have implemented methods to characterise cell behaviour of human iPS cells based on microscopy images collating data with genomics. This work has formed the basis for an innovative collaborative cell phenotyping space - The Stem Cell Hotel.

Davide was awarded the FLIER (Future Leader for Innovation Enterprise and Research) from the Academy of Medical Sciences. In parallel to his role at King's, he has recently joined an award winning Cambridge biotech.

He has several years of experience in high content analysis (both in live and end-point conditions) to characterise stem cell behaviour in academia and industry. He holds an MD from University of Milan and a PhD in Molecular Oncology from the European Institute of Oncology where he demonstrated the causative role of the HdmX protein in human cancer and completed his postdoctoral training with Austin Smith and Steve Pollard at University of Cambridge and University College London where he has developed screening platforms to isolate compounds active on human neural stem cells from brain tumour samples.